Drug
Olz Sam
Olz Sam: highest development phase Phase 3, developed by Alkermes. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Alkermes
Trials
| Drug | Phase | Indication |
|---|---|---|
| OLZ/SAM NCT05303064 | Phase 3 | Schizophrenia |
| OLZ/SAM NCT04987229 | Phase 3 | Bipolar I Disorder |
| OLZ/SAM NCT04987658 | Phase 1 | Bipolar I Disorder |
Latest
No recent events.
Follow Olz Sam on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.